更正：用于预测肝细胞癌预后和治疗反应的m7G相关长链非编码RNA特征的鉴定与验证
Correction: Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
作者信息
Peng Yue-Ling, Dong Ya-Fang, Guo Li-Li, Li Mu-Ye, Liao Hui, Li Rong-Shan
出版信息
PLoS One. 2025 Sep 5;20(9):e0331772. doi: 10.1371/journal.pone.0331772. eCollection 2025.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0289552.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0289552。]
相似文献
1
Correction: Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.更正：用于预测肝细胞癌预后和治疗反应的m7G相关长链非编码RNA特征的鉴定与验证
PLoS One. 2025 Sep 5;20(9):e0331772. doi: 10.1371/journal.pone.0331772. eCollection 2025.
2
Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.鉴定和验证与 m7G 相关的 lncRNA 特征，以预测肝细胞癌的预后和治疗反应。
PLoS One. 2023 Aug 3;18(8):e0289552. doi: 10.1371/journal.pone.0289552. eCollection 2023.
3
Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.新型 7-甲基鸟苷相关 microRNA 特征在乳腺浸润性癌中的预后和免疫意义：从探索到验证。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9105-9128. doi: 10.1007/s00432-023-04849-1. Epub 2023 May 12.
4
Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.更正：基于肝细胞癌坏死性凋亡相关基因的预后标志物的构建与验证
PLoS One. 2025 Sep 5;20(9):e0331773. doi: 10.1371/journal.pone.0331773. eCollection 2025.
5
Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing.通过单细胞和批量RNA测序的综合分析，鉴定并验证基于肝细胞特异性基因的肝细胞癌新型预测特征
BMC Med Genomics. 2024 Apr 23;17(1):103. doi: 10.1186/s12920-024-01871-1.
6
Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma.一种与铁死亡相关的长链非编码RNA特征作为肝细胞癌预后生物标志物的鉴定与验证
J Gastrointest Oncol. 2025 Jun 30;16(3):1092-1104. doi: 10.21037/jgo-2025-360. Epub 2025 Jun 24.
7
The joint role of the immune microenvironment and N-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia.免疫微环境和N-甲基鸟苷在急性髓系白血病预后预测及靶向治疗中的联合作用
Front Genet. 2025 Jun 13;16:1540992. doi: 10.3389/fgene.2025.1540992. eCollection 2025.
8
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
9
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.无锚定相关长非编码 RNA 特征可预测肝细胞癌的预后，并与免疫浸润相关。
Anticancer Drugs. 2024 Jun 1;35(5):466-480. doi: 10.1097/CAD.0000000000001589. Epub 2024 Mar 11.
10
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma.基于 RBM 家族的预后特征的综合生物信息学分析，并在肝细胞癌中进行实验验证。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11891-11905. doi: 10.1007/s00432-023-05084-4. Epub 2023 Jul 6.
本文引用的文献
1
Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.鉴定和验证与 m7G 相关的 lncRNA 特征，以预测肝细胞癌的预后和治疗反应。
PLoS One. 2023 Aug 3;18(8):e0289552. doi: 10.1371/journal.pone.0289552. eCollection 2023.
Zotero 插件